首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?
【24h】

Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?

机译:与大肠癌相关的常见遗传变异是否具有DNA错配修复基因突变携带者的风险?

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Genome-wide association studies have identified at least 15 independent common genetic variants associated with colorectal cancer (CRC) risk. The aim of this study was to investigate whether 11 of these variants are associated with CRC risk for carriers of germline mutations in DNA mismatch repair (MMR) genes. Methods: A total of 927 MMR gene mutation carriers (360 MLH1, 442 MSH2, 85 MSH6 and 40 PMS2) from 315 families enrolled in the Colon Cancer Family Registry, were genotyped for the single nucleotide polymorphisms (SNPs): rs16892766 (8q23.3), rs6983267 (8q24.21), rs719725 (9p24), rs10795668 (10p14), rs3802842 (11q23.1), rs4444235 (14q22.2), rs4779584 (15q13.3), rs9929218 (16q22.1), rs4939827 (18q21.1), rs10411210 (19q13.1) and rs961253 (20p12.3). We used a weighted Cox regression to estimate CRC risk for homozygous and heterozygous carriers of the risk allele compared with homozygous non-carriers as well as for an additive per allele model (on the log scale). Results: Over a total of 40,978 person-years observation, 426 (46%) carriers were diagnosed with CRC at a mean age of 44.3 years. For all carriers combined, we found no evidence of an association between CRC risk and the total number of risk alleles (hazard ratio [HR] per risk allele = 0.97, 95% confidence interval [CI] = 0.88-1.07, p = 0.52). Conclusions: We found no evidence that the SNPs associated with CRC in the general population are modifiers of the risk for MMR gene mutation carriers overall, and therefore any evidence of proven clinical utility in Lynch syndrome.
机译:背景:全基因组关联研究已鉴定出至少15种与大肠癌(CRC)风险相关的独立常见遗传变异。这项研究的目的是调查这些变异中的11个是否与DNA错配修复(MMR)基因中种系突变携带者的CRC风险相关。方法:对来自结肠癌家族登记处315个家庭的927个MMR基因突变携带者(360 MLH1、442 MSH2、85 MSH6和40 PMS2)进行单核苷酸多态性(SNP)的基因分型:rs16892766(8q23.3) ),rs6983267(8q24.21),rs719725(9p24),rs10795668(10p14),rs3802842(11q23.1),rs4444235(14q22.2),rs4779584(15q13.3),rs9929218(16q22.1),rs4939827(18q21) .1),rs10411210(19q13.1)和rs961253(20p12.3)。我们使用加权Cox回归来估计风险等位基因的纯合子和杂合子携带者与纯合子非携带者以及每个等位基因加性模型的CRC风险(在对数尺度上)。结果:在总共40,978人年的观察中,有426名(46%)携带者被诊断为CRC,平均年龄为44.3岁。对于所有合并的携带者,我们没有发现CRC风险与风险等位基因总数之间存在关联的证据(每个风险等位基因的风险比[HR] = 0.97,95%置信区间[CI] = 0.88-1.07,p = 0.52) 。结论:我们没有发现证据表明普通人群中与CRC相关的SNPs可以整体上修饰MMR基因突变携带者的风险,因此,没有任何证据证明在Lynch综合征中具有临床实用性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号